Marijuana Goes Mainstream, Ctd
Jonah Lehrer continues a discussion he began at the Dish:
I thought this brand new paper on stress and the cannabinoid receptor was extremely interesting. The Israeli scientists demonstrated that microinjecting an agonist of the CB1 receptor (a primary binding site of THC, the active ingredient in pot) significantly reduced the elevation of stress hormones in response to scary stressors. They researchers argue that their evidence "supports a wide therapeutic application for cannabinoids in the treatment of conditions associated with the inappropriate retention of aversive memories and stress-related disorders." Like I said before, pot just might be the next Prozac. Are you listening Eli Lilly?
(Image from the LA Times shows medical marijuana dispensaries in Los Angeles; Hat tip: Reason)